1. Search Result
Search Result
Isoforms Recommended: Wnt5
Results for "

WNT5A

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

6

Peptides

1

Inhibitory Antibodies

2

Recombinant Proteins

5

Antibodies

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99201
    Zilovertamab
    2 Publications Verification

    UC-961; Cirmtuzumab

    ROR Wnt Cancer
    Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling .
    Zilovertamab
  • HY-123071
    Box5
    Maximum Cited Publications
    11 Publications Verification

    Wnt Cancer
    Box5 is a potent Wnt5a antagonist. Box5 inhibits Wnt5a signaling and inhibits Wnt5a-mediated Ca 2+ release. Box5 inhibits cell migration. Box5 has the potential for the research of melanoma .
    Box5
  • HY-P1416
    Foxy-5
    5+ Cited Publications

    Wnt Cancer
    Foxy-5, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
    Foxy-5
  • HY-12557

    γ-Glu-Val

    Endogenous Metabolite CaSR Wnt TNF Receptor Interleukin Related PPAR β-catenin Inflammation/Immunology
    γ‑Glutamylvaline (γ-Glu-Val) is a calcium‑sensing receptor (CaSR) agonist. γ‑Glutamylvaline activates CaSR and facilitates its binding to β‑arrestin 2 to modulate inflammatory and metabolic homeostasis signaling. γ‑Glutamylvaline inhibits TNF‑α‑induced IL‑6/MCP‑1 and enhances adiponectin/PPARγ in adipocytes. γ‑Glutamylvaline upregulates Wnt5a, restores β‑catenin phosphorylation, and reduces serine‑phosphorylated IRS‑1 in adipocytes. γ-Glutamylvaline can be used for the research of low-grade chronic inflammation .
    γ-Glutamylvaline
  • HY-116553

    Wnt β-catenin Cancer
    FzM1 is a negative allosteric modulator (NAM) of Frizzled receptor FZD4. FzM1 reduces WNT5A-dependent WNT responsive element (WRE) activity (log EC50inh=?6.2). FzM1 binds to an allosteric binding site located in intracellular loop 3 (ICL3) of FZD4 and alters the conformation of the receptor, ultimately inhibiting the WNT/β-catenin cascade .
    FzM1
  • HY-123071A
    Box5 TFA
    Maximum Cited Publications
    11 Publications Verification

    Wnt Cancer
    Box5 TFA is a potent Wnt5a antagonist. Box5 TFA inhibits Wnt5a signaling and inhibits Wnt5a-mediated Ca 2+ release. Box5 TFA inhibits cell migration. Box5 TFA has the potential for the research of melanoma .
    Box5 TFA
  • HY-P1416A
    Foxy-5 TFA
    5+ Cited Publications

    Wnt Cancer
    Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
    Foxy-5 TFA
  • HY-RS15837

    Small Interfering RNA (siRNA) Others

    WNT5A Human Pre-designed siRNA Set A contains three designed siRNAs for WNT5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    WNT5A Human Pre-designed siRNA Set A
    WNT5A Human Pre-designed siRNA Set A
  • HY-RS17616

    Small Interfering RNA (siRNA) Others

    Wnt5a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Wnt5a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Wnt5a Mouse Pre-designed siRNA Set A
    Wnt5a Mouse Pre-designed siRNA Set A
  • HY-RS24076

    Small Interfering RNA (siRNA) Others

    Wnt5a Rat Pre-designed siRNA Set A contains three designed siRNAs for Wnt5a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Wnt5a Rat Pre-designed siRNA Set A
    Wnt5a Rat Pre-designed siRNA Set A
  • HY-P5171

    Wnt Cancer
    MDGCEL is a WNT5A peptide, that acts as a WNT5A mimicks and exhibits WNT5A antagonistic activity .
    MDGCEL

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: